Thursday, 30 July 2026 Scientists at the University of Nottingham have received funding from the National Institute for Health and Care Research (NIHR) to develop quantum sensing technology that will accurately predict the severity of liver disease in patients. The funding will enable the researchers to develop the new technology that will mean patients will have more personalised care after being diagnosed with liver disease. The team at Nottingham, led by Professor Lisa Chakrabarti in the School of Veterinary Medicine and Science, has received the funding through the NIHR Invention for Innovation Funding At Speed of Translation (FAST) opportunity. The project is one of 17 quantum healthcare innovations funded through the programme. The project team also includes Professor Melissa Mather from the School of Engineering, Professor Mark Fromhold from the School of Physics and Dr Aloysious Aravinthan from the School of Medicine. Chronic liver disease (CLD) is a growing cause of serious il...
Our project is Precise Detection of High-Risk Chronic Liver Disease using Diamond Quantum Sensing Dr. Chloe Sargent is the post-doctoral research associate we have been fortunate tobe able to engage on this project. The projects have been funded through the NIHR Invention for Innovation (i4i) Funding At the Speed of Translation (FAST) opportunity. This connects leading UK quantum research with clinical expertise and NIHR infrastructure. It will help promising technologies move more quickly towards follow-on development and NHS use. Professor Mike Lewis, NIHR Scientific Director for Innovation said: "This funding is a major step forward in bringing quantum technology to patients, cementing the UK as Europe’s leader in quantum health innovation. "By investing in these 17 projects, we are fast-tracking tools that can diagnose illness earlier and provide life-changing breakthroughs. These innovations will transform our health system and improve the lives of patients." H...